Cargando…
A randomized, controlled, comparative, proof-of-concept study to evaluate the efficacy and safety of Nisha-Amalaki capsules in prediabetic patients for preventing progression to diabetes
BACKGROUND: Prediabetes is an intermediate state of hyperglycemia, which acts as a precursor to Diabetes mellitus if left untreated. Nisha (Curcuma longa) and Amalaki (Emblica officinalis) combination has been advocated as drugs of choice to treat the early manifestations of Diabetes mellitus. OBJEC...
Autores principales: | Munshi, Renuka, Karande-Patil, Shilpa, Kumbhar, Dipti, Deshmukh, Amol, Hingorani, Lal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587713/ https://www.ncbi.nlm.nih.gov/pubmed/37857033 http://dx.doi.org/10.1016/j.jaim.2023.100806 |
Ejemplares similares
-
An open labeled, randomized, controlled clinical study to evaluate the efficacy of Torchnil capsules and Febcin tablet as add-on therapy for Covid-19 patients
por: Munshi, Renuka, et al.
Publicado: (2022) -
Immunomodulatory activity of Āmalaki Rasāyana: An experimental evaluation
por: Rajani, Jignesh, et al.
Publicado: (2012) -
A survey of the labeling information provided for ayurvedic drugs marketed in India
por: Bhalerao, Supriya, et al.
Publicado: (2010) -
Clinical efficacy of Amalaki Rasayana in the management of Pandu (Iron deficiency anemia)
por: Layeeq, Shaizi, et al.
Publicado: (2015) -
Does Panchatikta ghrita have anti-osteoporotic effect? Assessment in an experimental model in ovariectomized rats
por: Munshi, Renuka, et al.
Publicado: (2021)